REC-4881 is an orally bioavailable, non-ATP-competitive allosteric small molecule MEK 1/2 inhibitor. The platform analyzed cellular models of APC gene loss-the root cause of FAP-to identify compounds ...

GI Alliance and Iterative Health have formed a strategic partnership to expand access to clinical trials across ...

Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

Ayna joins Antag with extensive experience in obesity and clinical pharmacology. She most recently served as Senior Principal ...

Scientific research continues to uncover interesting connections between the gut microbiome and human health, including ...

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...

Investigate the role of seed cycling in women's health, particularly its effects on hormonal regulation and PCOS symptom ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

SparX Biopharma to present phase 1 clinical updates of SPX-303, a dual checkpoint bispecific antibody, during AACR 2025: Chicago Monday, April 21, 2025, 16:00 Hrs [IST] SparX Biop ...

Neuroscientists have developed a new treatment approach for a language disorder that combines traditional speech therapy with noninvasive electrical stimulation of the brain. Brain stimulation helped ...

Trials are used to test potential medicines, treatments or procedures. The National Institutes for Health define a clinical ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...